-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O3.6 623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Aggressive NHL – MCL, Burkitt, T-cell

Lymphoma: Chemotherapy, excluding Pre-Clinical Models Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 4:30 PM-6:00 PM
Hall E2, Level 2 (Orange County Convention Center)
Moderators:
Kami J. Maddocks, MD, The Ohio State University and Stefano Luminari, MD, University of Modena and Reggio Emilia

Disclosures:
Maddocks: Janssen: Research Funding ; Novartis: Research Funding ; Pharmacyclics: Consultancy , Research Funding .
4:30 PM

Lawrence D. Kaplan, MD1, Sin-Ho Jung, PhD2*, Wendy Stock, M.D.3, Nancy L. Bartlett, MD4, Brandelyn Pitcher, MS2*, John C. Byrd, MD5, Kristie A. Blum, MD6, Ann S. LaCasce, MD7, Noreen Fulton8*, Eric D. Hsi, MD9, David D Hurd, MD10, Myron Czuczman11, John P. Leonard, MD12 and Bruce D. Cheson, MD13

1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
2Alliance Statistics and Data Center, Duke University, Durham, NC
3Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
4Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
5Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
6Division of Hematology, The Ohio State University, Columbus, OH
7Dana-Farber Cancer Institute, Boston, MA
8University of Chicago Medical Center, Chicago, IL
9Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH
10Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC
11Medical Oncology, Roswell Park Cancer Institute, Buffalo
12Department of Medicine, Weill Cornell Medical College, New York, NY
13Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC

4:45 PM

Mary B Callanan, PhD1,2*, Marie-Hélène Delfau, MD, PhD3*, Elizabeth Macintyre, MD, PhD4, Catherine Thieblemont5, Lucie Oberic, MD6*, Emmanuel Gyan, MD, PhD7, Krimo Bouabdallah, MD8*, Remy Gressin, MD2,9, Gandhi Damaj, MD, PhD10, Olivier Casasnovas, MD11*, Vincent Ribrag, MD12, Estelle Gimenez, MSc2,13*, Olivier Hermine14* and Steven Le Gouill, MD, PhD15*

1Laboratoire de Génétique Onco-Hématologique, CHU de Grenoble, GRENOBLE, France
2Centre de Recherche INSERM - Université Joseph Fourier-Grenoble I, U823, Grenoble, France
3Department of Biological Hematology and immunology, Assistance Publique Hopitaux de Paris (APHP), Groupe Hospitalier Mondor, Creteil, France
4Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France
5Hôpital Saint-Louis, Paris, France
6Department of Hematology, Purpan University Hospital, Toulouse, France
7Service d’Hématologie et Thérapie Cellulaire, UMR CNRS 7292, CHU de Tours, Tours, France
8CHU de Bordeaux, Bordeaux, France
9Service d'hématologie clinique, CHU Grenoble, Grenoble, France
10Hematology Department, CHU Caen, Caen, France
11Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France
12DITEP/medicine, Gustave Roussy Cancer Campus, Villejuif, France
13Pole Recherche, CHU de Grenoble, Grenoble, France
14Department of Hematology, Necker Children's hospital, APHP, Paris, France
15Department of hematology, Nantes university Hospital and UMR892 INSERM, Nantes, France

5:00 PM

Jeanette K Doorduijn, MD, PhD1, Monique C. Minnema, MD, PhD2, Marie Jose Kersten, MD, PhD3, Pieternella J Lugtenburg, MD, PhD1, Martin R. Schipperus, MD, PhD4, Marinus van Marwijk Kooy, MD, PhD5*, Marius MacKenzie, MD. PhD6*, Josée M Zijlstra, MD, PhD7*, Henriette W Berenschot, MD8*, M. R Schaafsma, MD, PhD9, Dana A Chitu, PhD10* and Hanneke C. Kluin-Nelemans, MD, PhD11

1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
2Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, Netherlands
3Hematology, Academic Medical Center, Amsterdam, Netherlands
4Haga Teaching Hospital, The Hague, Netherlands
5Department of Internal Medicine, Isala Clinic, Zwolle, Netherlands
6hematology, UMCN, Nijmegen, Netherlands
7Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, Netherlands
8Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
9Medisch Spectrum Twenthe, Enschede, Netherlands
10HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands
11Department of Hematology, Groningen University Medical Center, University of Groningen, Groningen, Netherlands

5:15 PM

Henrik Cederleuf, MD1*, Martin Bjerregård Pedersen, MD, PhD2*, Mats Jerkeman, MD, PhD3, Thomas Relander, MD, PhD4*, Francesco d'Amore, MD5 and Fredrik Ellin, MD, MSc6*

1Department of Oncology, Scania University Hospital, Lund, Lund, Sweden
2Department of Hematology, Aarhus University Hospital, Aarhus C, Denmark
3Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden
4Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden
5Dept. of Hematology, Aarhus University Hospital, Aarhus, Denmark
6Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden

5:30 PM

Owen A. O'Connor, MD, PhD1*, Muhit Özcan, MD2*, Eric D. Jacobsen, MD3, Josep Maria Roncero Vidal, MD4*, Judith Trotman, MBChB5, Judit Demeter, MD, PhD, DsC6*, Tamás Masszi, MD7*, Juliana Pereira, MD, PhD8*, Radhakrishnan Ramchandren, MD9*, Francesco A. d'Amore, MD, PhD10*, Francine Foss, MD11, Won-Seog Kim, MD, PhD12*, John P. Leonard, MD13, Carlos Sérgio Chiattone, MD, PhD14, Pier Luigi Zinzani, MD, PhD15, Hua Liu, PhD16*, JungAh Jung, PhD16*, Xiaofei Zhou, PhD17*, E. Jane Leonard, MSc18*, Claudio Dansky Ullmann, MD18* and Andrei R. Shustov, MD19

1Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY
2Department of Hematology & BMT, Ankara University Medical School, Cebeci Hospital, Dikimevi, Ankara, Turkey
3Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Clinical Hematology, Catalan Institute of Oncology, Girona, France
5Department of Hematology, Concord Repatriation General Hospital, Concord, NSW, Australia
6First Department of Internal Medicine, Division of Haematology, Semmelweis University, Budapest, Hungary
7Department of Haematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest, Hungary
8Department of Hematology, University of São Paulo Medical School, São Paulo, Brazil
9Hematology/Oncology, Karmanos Cancer Institute, Detroit, MI
10Hematology, Aarhus University Hospital, Bethesda, MD
11Yale Hematology/Cutaneous Lymphoma, Smilow Cancer Hospital at Yale-New Haven, New Haven, CT
12Department of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea
13Weill Cornell Medical College, New York, NY
14Department of Hematology and Oncology, Santa Casa Medical School, Sao Paulo, Brazil
15Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
16Biostatistics, Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
17Clinical Pharmacology, Millennium Pharmaceuticals Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
18Oncology Clinical Research, Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
19University of Washington Medical Center – Seattle Cancer Care Alliance & Fred Hutchinson Cancer Research Center, Seattle, WA

5:45 PM

Kieron Dunleavy, MD1, Ariela Noy, MD2, Jeremy S. Abramson, MD3, Ann S. LaCasce, MD4, Brian K Link, MD5, Samir Parekh, MD6, Deepa Jagadeesh, MD, MPH7, Philip J Bierman, MD8, Ronald T. Mitsuyasu, MD9*, Ramakrishna Battini, MD10*, Peter R Watson, MD11*, David Peace, MD12, Bruce J Averbrook, MD13*, Harris V. Naina, MD14, Joseph W Leach, MD15*, Wahid T Hanna, MD16, Bayard L. Powell, MD17, Sunil Nagpal, MD18*, Mark Roschewski, MD1, Andrea N Lucas, RN19*, Seth M. Steinberg, PhD20*, Brad S Kahl, MD21, Jonathan W. Friedberg, MD, MMSc22, Richard F Little, MD, MPH23, Nancy L Bartlett, MD24, Michelle A. Fanale, MD25 and Wyndham H Wilson, MD, PhD1

1Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD
2Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
6Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
7Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
8Univ. of Nebraska Medical Center, Omaha, NE
9UCLA Medical Center, Los Angeles, CA
10Department of Oncology, Montefiore Medical Center, New York, NY
11Kinston Medical Specialists, Kinston, NC
12Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
13Metrohealth Medical Center, Cleveland, OH
14Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
15Unity Hospital, Monneapolis, MN
16University of Tennessee Cancer Institute, Knoxville, TN
17Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC
18West Michigan Cancer Center, Kalamazoo, MI
19Center for Cancer Research, National Cancer Institute, Bethesda, MD
20Biostatistics and Data Management Section, National Cancer Institute, Bethesda, MD
21Washington University, St.Louis, MO
22University of Rochester, Rochester, NY
23Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD
24Washington University School of Medicine, Saint Louis, MO
25Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH